Cardio Diagnostics (CDIO) said Thursday its Epi+Gen CHD clinical blood test is now available at Family Medicine Specialists' retail clinical location at the Meijer Supercenter in McHenry, Illinois.
The test predicts the odds that an individual will have a heart attack or experience sudden death related to coronary heart disease in the next three years, the company said.
Cardio Diagnostics shares were up 4.4% in recent trading.
Price: 0.55, Change: +0.02, Percent Change: +4.42
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments